Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

GALE 1.80 -0.03 (-1.64%)
price chart
Why Galena Biopharma, Inc. Stock Crashed By 52% in 2014
The overall market may be on pace to deliver solid gains for investors in 2014, but shareholders in Galena Biopharma (NASDAQ: GALE ) can do nothing but shake their head in disappointment with their stock down 52% for the year.
Related articles »  
Could Galena Biopharma, Inc. Be Running Out of Money?
Today, we're going to take a closer look at small-cap biopharmaceutical company Galena Biopharma (NASDAQ: GALE ) to get a better bead on what its current cash situation looks like, to determine whether or not it could be running out of money, and to ...
Stocks to watch: Galena Biopharma, Inc. (NASDAQ:GALE), TIBCO Software Inc ...
In the Healthcare sector, Galena Biopharma, Inc. (NASDAQ:GALE) saw a change of -3.17%. It was a change from open of- 3.680% at the close of today's trading.
Why Galena Biopharma Inc. Stock Tumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Galena Biopharma Reports Second Quarter 2014 Results  GlobeNewswire (press release)
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Stocks to watch: Galena Biopharma, Inc. (GALE), GoPro, Inc. (GPRO)
In the Healthcare sector, Galena Biopharma, Inc. (GALE) saw a change of 0.00%. It was a change from open of 0.00%. Galena Biopharma, Inc. (GALE) closed for the day at $1.83, with the weekly change of- 0.54%. Galena Biopharma, Inc. (GALE)'s change in ...
Darks Clouds Hover Over These Three Stocks: Galena Biopharma Inc (NASDAQ ...
Galena Biopharma Inc (NASDAQ:GALE) turned lower on Monday after The Street's Adam Feuerstein provided negative commentary on the stock and reminded investors the company is still under active SEC investigation for paying outside firms to promote its ...
Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare ...
Galena Biopharma, Inc. GALE, -3.17% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced that Mark W.
Worst Year-To-Date Performers: VIVUS, Inc. (VVUS), Galena Biopharma Inc ...  Investor Wired (press release)
News Recap: Galena Biopharma, Inc. (NASDAQ:GALE), Magnum Hunter ...  Market News Call
Related articles »  
Rarely Bears Walks In Biotech Industry- Galena Biopharma Inc (NASDAQ:GALE ...
Galena Biopharma Inc (NASDAQ:GALE) [Detail Analytic Report] declared on Tuesday that Mark W. Schwartz, Ph.D., President and CEO will present a corporate update at the Oppenheimer 25th Annual Healthcare Conference.
Related articles »  
Bull Runs At Biotech Industry- Galena Biopharma Inc (NASDAQ:GALE), VIVUS ...
Shares of Galena Biopharma Inc (NASDAQ:GALE) [Detail Analytic Report] show bullish performance by surging 11.29% in last trading session after the firm declared the finalization of an acquisition deal for above $55.0 million with Lincoln Park Capital ...
Hot Stocks: Galena Biopharma Inc (NASDAQ:GALE), Equinix Inc (NASDAQ ...
Galena Biopharma Inc (NASDAQ:GALE) has been in a very strong downtrend over the past couple of weeks, the stock has broken below all important daily moving averages which is a huge cause for concern for traders and investors.
Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With ...  Nasdaq
Related articles »